LED Medical Diagnostics Inc. TSXV: LMD / OTCQB:LEDIF
|
|
- Cameron Palmer
- 5 years ago
- Views:
Transcription
1 LED Medical Diagnostics Inc. TSXV: LMD / OTCQB:LEDIF
2 WHAT WE DO LED Medical Diagnostics Inc. provides software and imaging device solutions to Dentists, Dental Support Organizations (DSOs) & the US Military Dental Command 2
3 PROBLEMS WE SOLVE FOR OUR CUSTOMERS Software solutions that unlocks Dentists, DSOs & Dental Command from competitive closed proprietary software and devices Provides secure hosted single database solution for image storage, analysis, retrieval and sharing from any web enabled device Solves image accessibility issues and reduces IT costs for DSOs Provides (SaaS) imaging solutions for partnering with cloud based- dental practice management solutions Patterson Dental, Planet DDS, CareStack, DentiMax and others 3
4 OUR SOFTWARE & DEVICE SOLUTIONS Apteryx Software TUXEDO Sensor VELscope Vx RAYSCAN α / LED IC100 Patented Software XrayVision XrayVisionDCV XV Web Digital intra oral x-ray Proprietary Early detection oral disease VELcap consumables Market Leader Patented Digital extra-oral x-ray Intra oral camera Distributed / OEM 4
5 U.S. MARKET OPPORTUNITY Dentists (2016) TAM = 191,772 Dentists working in dentistry in 2017 SAM = 16,213 DSO-Affiliated Solo or Group Practices DSOs = 8% of total practices in the United States DSO Solo DSO Solo or Group Non DSO Solo US market for dental digital imaging is world s largest and growing with market estimated to exceed $1.7B by 2020 Source idata
6 TRENDS DRIVING GROWTH DSOs now own or control approximately 8 percent of total practices in the United States and expected to grow at approximately 15 percent annually over the next five years *US penetration could reach 30 percent by 2021 Rapidly expanding growth of cloud based dental practice management software models The medical software industry has evolved toward cloud-based computing over the past decade and the dental industry is finally following in its footsteps. 6 *Source William Blair report
7 BUSINESS STRATEGY - Recurring / Repeatable Revenue Promote XVWeb and DCV (client server solution) to Dental Service Organizations (DSOs) through participation at national conferences, organizational sponsorships and advertising in key industry publications, targeted campaigns, web site, white papers and blogs Build strategic relationships with dental practice management vendors, focusing on synergies between their technologies and XVWeb (Patterson FUSE, QSI, Dental Planet, etc.) Leverage existing VELscope and Apteryx customer base as prospect pipeline for Tuxedo and software solutions focus on workflow / service / support Single vendor solution advantage US Government leveraging US Military relationship GSA contract 7
8 TEAM David Gane - CEO Vince Wagner - Sales Chris Koch - Marketing Kevin Crucs SW Development Lamar Roberts - Sales & Marketing Michaela Ragoonath - R&D 8
9 LED FINANCIAL PERFORMANCE (US$M) Highlights from 2017 include: Acquisition of Apteryx, bringing subscription Software as a Service (SaaS) recurring revenue model New customer wins, including significant Dental Service Organizations (DSOs) & Patterson Dental Revenue US$ 12.7M increase of 25% for the full year 2017 over 2016 Gross margin improvement of more than 100% to 56% for 2017 vs. 24% for 2016 EBITDA improvement of more than US$3 million Reduced net loss YoY by nearly US$3 million Recent Qs more closely reflects our current business growth and is expected to be sustainable with similar margins 9
10 COMPANY OVERVIEW Exchange: Ticker Market Cap. (as at: 7/10/2018) Price (as of: 7/10/2018) Common Shares Outstanding Outstanding Fully Diluted CDN $0.60 (expire Feb 11, 2019) CDN $1.00 (expire Feb 10, 2019) CDN $1.00 (expire Oct 30, 2019) TSXV: LMD (OTCQB: LEDIF) CAN $15.4M (TSXV) CAN $0.405 (TSXV) 37,914,636 53,407,313 1,326,286 11,070,753 12,485,839 88, Stock Options Management Ownership Total Debt 2,970,833 ~11% US $5.9M* * Debenture balance per FS expressed net of fair value of warrants from financings that have been classified as equity with gross debenture and accrued interest payable as at march 31 approx. US $6.5M
11 SUMMARY Patented open architected software solutions integrating with a wide variety of imaging devices and dental management software systems Proven software development teams in niche dental imaging market Extensive management experience in the dental industry, DSO and government market segments Substantial user base of existing VELscope and Apteryx customers Strong intellectual property portfolio 40 issued digital imaging related patents 11 Significant customer wins, including Dental Service Organizations (DSOs) & leading dental practice management software companies
12 See the difference 580 Hornby Street, Unit 810 Vancouver, British Columbia V6C 2E Investor Relations Contact David Gane Tel: x227
January 30, 2018 Dow Wilson President and Chief Executive Officer
Acquisition of SIRTeX January 30, 2018 Dow Wilson President and Chief Executive Officer This presentation is intended exclusively for investors. It is not intended for use in Sales or Marketing. Forward-Looking
More informationMarketing Makeover. Look Good in a Crowded. Strategies that Make You. Cloud Marketplace
Proprietary information of Ingram Micro Inc. Do not distribute or duplicate without Ingram Micro s express written permission. Marketing Makeover Strategies that Make You Look Good in a Crowded Cloud Marketplace
More informationDelivering Results POSITIONED FOR GROWTH. Analyst & Investor Day October 14, 2015 Paul Guggenheim CEO, Patterson Dental
Delivering Results POSITIONED FOR GROWTH Analyst & Investor Day October 14, 2015 Paul Guggenheim CEO, Patterson Dental PAUL GUGGENHEIM CEO, Patterson Dental Former owner and president, Guggenheim Brothers
More informationForward-looking Statements
September 2011 Forward-looking Statements Information contained in this presentation may contain forward-looking statements, including, but not limited to: the expectation that Easy Check and GlucoChip
More informationVITROLIFE AB (PUBL) NORDEA Small & Mid Cap Seminar
VITROLIFE AB (PUBL) NORDEA Small & Mid Cap Seminar 2018-08-16 1 2 10 15 % OF ALL COUPLES IN FERTILE AGE SUFFER FROM FERTILITY PROBLEMS LEADING COMPANY IN MEDICAL DEVICES FOR ASSISTED REPRODUCTION A Swedish
More informationVITROLIFE AB (PUBL) Pareto Securities Health Care Conference
VITROLIFE AB (PUBL) Pareto Securities Health Care Conference 2018-09-06 1 2 10 15 % OF ALL COUPLES IN FERTILE AGE SUFFER FROM FERTILITY PROBLEMS LEADING COMPANY IN MEDICAL DEVICES FOR ASSISTED REPRODUCTION
More informationForward-Looking Statements
Investor Presentation May 2012 Forward-Looking Statements Statements contained herein that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933, as amended.
More informationST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015
ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015 1 FORWARD LOOKING STATEMENT This presentation contains forward-looking statements within the meaning of the Private Securities Litigation
More informationThe Dental Corporation Opportunity
The Dental Corporation Opportunity for Practice Principals. It s the perfect professional collaboration. You focus on dentistry, we look after the paperwork. In recognition of what you, the Practice Principal,
More informationGenomic Health. Kim Popovits, Chairman, CEO and President
Genomic Health Kim Popovits, Chairman, CEO and President Safe Harbor Statement Various remarks that we make in this presentation that are not historical, including those about our future financial and
More informationDIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM
November 28, 2017 DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM Dr. Jürgen Wunram Agenda Diebold Nixdorf AG History and shareholder structure Market trends, strategy and progress of integration Diebold Nixdorf
More informationInvestor Presentation June 2012 NASDAQ: CEMI
Investor Presentation June 2012 NASDAQ: CEMI Forward-Looking Statements Statements contained herein that are not historical facts are forward-looking statements within the meaning of the Securities Act
More informationAcquisition of Novartis Influenza Vaccines Business. 27 th October 2014
1 Acquisition of Novartis Influenza Vaccines Business 27 th October 2014 2 Legal Notice Forward looking statements The materials in this presentation speak only as of the date of these materials, and include
More informationVisionary Private Equity Group is Pleased to Announce its Investment in MEDITE Cancer Diagnostics
Dear VPEG Limited Partner, We hope this investor update finds you well. We're pleased to share with you an important update below on the following: Visionary Private Equity Group is Pleased to Announce
More informationCorporate Presentation October New growth cycle and value innovation
Corporate Presentation October 2017 New growth cycle and value innovation Index 1 Dental benefits: an incipient sector in Brazil 2 Inside OdontoPrev 3 Strategic competitive advantages 4 Financial and Operational
More informationStraumann s net revenues reach CHF 185 million in Q1, driven by continuing double-digit growth in America
Media release Straumann s net revenues reach CHF 185 million in Q1, driven by continuing double-digit growth in America Group net revenue rises 2% (l.c.) as double-digit increases across America offset
More informationSecond Quarter and First Half 2011 Conference Call. 29 July, SORIN GROUP Presentation 1
Second Quarter and First Half 2011 Conference Call 29 July, 2011 SORIN GROUP Presentation 1 DISCLAIMER This presentation contains management preliminary estimates and forward-looking statements, including
More informationA world leader in allergy immunotherapy
A world leader in allergy immunotherapy Investor Relations presentation June 2017 1 I Investor Relations presentation I June 2017 ALK: Towards redefining treatment of severe allergies The commercial leader
More informationCIM1309: vcat 3.0: Operating a VMware Cloud
CIM1309: vcat 3.0: Operating a VMware Cloud Kevin Lees - Principal Architect Global Centers of Excellence Rohan Kalra Business Solutions Architect, VMware Global Center of Excellence 2009 VMware Inc. All
More informationASX Investor Presentation
ASX Investor Presentation Sydney, Australia Dr Peter Neustadt Executive Chairman and CEO November 2014 Copyright and registered trademark notice ASX Investor Presentation Page 0 Who we are SomnoMed Limited
More informationLeading Cannabinoid Patient Care in Canada. Corporate Presentation July 2017 TSXV: CMM OTCQB: CAMDF
Leading Cannabinoid Patient Care in Canada Corporate Presentation July 2017 TSXV: CMM OTCQB: CAMDF Forward Looking Statements Except for historical information, this presentation contains forward-looking
More informationBALCHEM CORPORATION. Q Investor Relations Presentation
BALCHEM CORPORATION Q4 2017 Investor Relations Presentation Balchem Corporation Balchem develops, manufactures, and markets specialty ingredients that improve and enhance the health and well being of life
More information34 th Annual J.P. Morgan Healthcare Conference
JANUARY 2016 34 th Annual J.P. Morgan Healthcare Conference [ 1 ] Forward Looking Statements SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS In addition to historical information, this presentation contains
More information2018 Global Value-based Digital Dental Competitive Strategy Innovation and Leadership Award
2018 Global Value-based Digital Dental Competitive Strategy Innovation and Leadership Award 2018 Contents Background and Company Performance Industry Challenges... 3 Strategy Innovation and Customer Impact...
More informationQUALITAS MEDICAL GROUP LIMITED. CORPORATE PRESENTATION January 2010
QUALITAS MEDICAL GROUP LIMITED CORPORATE PRESENTATION January 2010 Contents Our Business Corporate Developments Growth Strategies Financial Highlights Summary Business Overview Who We Are Established in
More informationTo be the partner of choice Straumann
To be the partner of choice Straumann Gilbert Achermann, CEO Helvea Swiss Equities Conference 11 January 2008, Bad Ragaz Table of contents 1. A snapshot of Straumann 2. Financials 3. Markets and opportunities
More informationNestlé Investor Seminar 2008
Nestlé Investor Seminar 2008 Nestlé Nutrition update on Acquisitions Richard Laube CEO Nestlé Nutrition 1 Disclaimer This presentation contains forward looking statements which reflect Management s current
More informationColoplast A/S. Investor presentation 1H 2005/06
Coloplast A/S Investor presentation 1H 2005/06 2 Coloplast Coloplast products and services help patients achieve greater independence from medical challenges in 4 areas: Ostomy care, continence care, wound
More informationInvestor Presentation September Cogstate Ltd. All rights reserved.
Investor Presentation September 2017 2017 Cogstate Ltd. All rights reserved. We believe that brain health is profoundly important to quality of life and should be easier to measure. That s why we so passionately
More informationMyriad Genetics Corporate Presentation 06/13/2018
Myriad Genetics Corporate Presentation 06/13/2018 Copyright 2016 2018 Myriad Genetics, Inc., all rights reserved. www.myriad.com. 1 Forward Looking Statements Some of the information presented here today
More informationDIABETES CARE DEVICES MARKET IN BRAZIL, RUSSIA, INDIA & CHINA (BRIC)
DIABETES CARE DEVICES MARKET IN BRAZIL, RUSSIA, INDIA & CHINA (BRIC) R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p
More informationTrends in the Development of the Dental Service Organization (DSO) Model: Implications for the Oral Health Workforce and Access to Services
Trends in the Development of the Dental Service Organization (DSO) Model: Implications for the Oral Health Workforce and Access to Services Presented by: Margaret Langelier Deputy Director Oral Health
More informationStraumann reports 4% growth in local currencies (l.c.) in the first nine months of 2010
Media release Straumann reports 4% growth in local currencies (l.c.) in the first nine months of 2010 Growth driven by implant volumes, lifted by Bone Level implant range and Roxolid Third quarter (+3%
More informationFor personal use only
Australian Securities Exchange Limited Companies Announcements Office SYDNEY 4 April, 2012 New Australian Drug Developer Lists on ASX Key points Growth-focused Australian drug and therapeutic development
More informationSCANNER & SERVICES OVERVIEW
SCANNER & SERVICES OVERVIEW Tim Mack VP BUSINESS DEVELOPMENT & GM ITERO 1 2014 Align Technology, Inc. 1 FORWARD LOOKING STATEMENT During this presentation and corresponding commentary we may make forwardlooking
More informationFY2016 1H Results. Cookpad Inc.
FY2016 1H Results Cookpad Inc. 1 1H Highlights Premium Service -Premium Service revenue increased by 39.6% YoY. -Number of premium members grew by 12.0% YoY to exceed 1.85 million. Advertising -Advertising
More informationGrupo Fleury announces the acquisition of Grupo Papaiz, entering the dental diagnostics market. September 28th, 2012
Grupo Fleury announces the acquisition of Grupo Papaiz, entering the dental diagnostics market September 28th, 2012 All rights reserved 2012 Disclaimer This presentation may contain forward-looking statements.
More informationUniversal Biosensors, Inc.
Universal Biosensors, Inc. ARBN 121 559 993 Buchan Three Tickers Presentation 18 th September 2013 1 Important Disclaimer This presentation is intended to provide a general outline only and is not intended
More informationIntercell and Novartis form world leading strategic partnership to drive vaccines innovation
Intercell and Novartis form world leading strategic partnership to drive vaccines innovation Alliance creates opportunity for two strong innovators to combine development efforts in attractive areas Intercell
More informationInvestor Presentation May 2016
Investor Presentation May 2016 Forward Looking Statements Any statements contained in this presentation that do not describe historical facts may constitute forwardlooking statements as that term is defined
More informationKAPITALMARKNADSDAG 20 SEPTEMBER Thomas Axelsson, CEO
KAPITALMARKNADSDAG 20 SEPTEMBER 2016 Thomas Axelsson, CEO 1 AGENDA 16.10-16.30 VD har ordet Thomas Axelsson, CEO 16.30-16.50 Clinical relevance of time-lapse Dr. Niels B. Ramsing, Business Unit Time-lapse,
More informationForward Looking Information
Vital Signs, Inc. Forward Looking Information Except for historical information discussed, the statements made today are forward-looking statements that involve risks and uncertainties. Investors are cautioned
More informationELICA 2012 Q3 RESULTS. November 14,
ELICA ELICA 1 Q3 12 Highligths Negative market demand, showing better trend compared to previous quarters Group sales over performing in all major markets Cost reduction efforts and continued product innovation
More informationALLERGAN TO ACQUIRE ZELTIQ FOR $2.47B BEST-IN-CLASS COMPANY IN FAST GROWING BODY CONTOURING SEGMENT
ALLERGAN TO ACQUIRE ZELTIQ FOR $2.47B BEST-IN-CLASS COMPANY IN FAST GROWING BODY CONTOURING SEGMENT ALLERGAN CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS Statements contained in this presentation
More informationResMed Inc. 36 th Annual J.P. Morgan Healthcare Conference
ResMed Inc. 36 th Annual J.P. Morgan Healthcare Conference Mick Farrell CEO January 8, 2018 Safe Harbor Statement Statements contained in this presentation that are not historical facts are forwardlooking
More informationGlobal Invisible Braces Market: Trends, Opportunities and Forecasts ( )
Global Invisible Braces Market: Trends, Opportunities and Forecasts (2016-2021) By Types Clear Aligners, Ceramic, Lingual By Region Americas, Europe, Middle East, Africa, Asia-Pacific By Country- USA,
More informationTEETH TOMORROW NETWORK FOR ADVANCED IMPLANT DENTISTS. Teeth Tomorrow. Dental Implant Bridge
TEETH TOMORROW NETWORK FOR ADVANCED IMPLANT DENTISTS Teeth Tomorrow Dental Implant Bridge OPPORTUNITY Teeth Tomorrow is an opportunity only available to carefully selected Advanced Implant Dentists. Teeth
More informationEVENT REGISTRATION FORM (for local chapter planning purposes only)
EVENT REGISTRATION FORM (for local chapter planning purposes only) School Please complete the following form listing the names and grades (9-12) of students entering the event specified and use it as the
More informationClosing of Nucletron acquisition Building a stronger position in the cancer care market. September 15, 2011
Closing of Nucletron acquisition Building a stronger position in the cancer care market September 15, 2011 Important step in Elekta s growth strategy Nucletron is the world leader in Brachytherapy and
More informationJanuary 2017 Investor Presentation. confidently live life with ease
January 2017 Investor Presentation confidently live life with ease Forward-Looking Statements This presentation contains certain forward-looking statements that involve risks and uncertainties that could
More informationLetter to Shareholders
Letter to Shareholders February 2019 Dear Fellow Shareholders: As Co-Founder and Chief Executive Officer of Medicine Man Technologies, Inc. (OTCQX: MDCL), I want to thank you for being a shareholder in
More informationIntroducing the VELscope Vx
Introducing the VELscope Vx 888.541.4614 sales@leddental.com www.leddental.com Introducing the VELscope Vx What is the VELscope Vx? The VELscope Vx, the latest model release of LED Dental s VELscope technology,
More informationAnnual General Meeting 25 October Cogstate Ltd. All rights reserved.
Annual General Meeting 25 October 2017 2017 Cogstate Ltd. All rights reserved. Board of Directors Audit, Risk & Compliance Committee Remuneration & Nomination Committee Martyn Myer Non-Exec Chairman Yes
More informationAADB 135 th Annual Meeting
AADB 135 th Annual Meeting DSOs: Supporting Dentists to Increase Access to Quality Affordable Care 9/23/18 Introductions Rick Workman, DMD, Founder & Executive Chairman, Heartland Dental A.J. Acierno,
More informationCompany Overview February 26, 2019
Company Overview February 26, 2019 SAFE HARBOR Cautionary Note Regarding Forward-Looking Statements Certain statements in this presentation constitute forward-looking statements, including, without limitation,
More informationA SIMPLIFIED PROCESS TO LIQUIDATE POWERSPORTS INVENTORY AND MAXIMIZE RETURNS
Since 1990, National Powersport Auctions (NPA) has maintained its position as the worldwide leader in powersport remarketing. NPA is known for the largest inventories of motorcycles, ATV s, UTV s, RV s,
More informationCorporate Presentation 1Q18. New growth cycle and value innovation
Corporate Presentation 1Q18 New growth cycle and value innovation Index 1 Dental benefits: an incipient sector in Brazil 2 Inside OdontoPrev 3 Sustainability 4 Strategic competitive advantages 5 Financial
More informationA GLOBAL LEADER IN PERSONALIZED NUTRITION
A GLOBAL LEADER IN PERSONALIZED NUTRITION Forward Looking Statements Management will make forward-looking statements during this presentation. Actual results could differ from those projected in such forward-looking
More informationWalgreens (WAG) Analyst: Juan Fabres Fall 2014
Recommendation: Buy Target Price August 31, 2016: $77.57 1. Reasons for the Recommendation With the acquisition of Alliance Boots in Europe, Walgreens will be the first US pharmacy to operate retail stores
More informationBetter Diagnostics for Life
NASDAQ: NMRD Better Diagnostics for Life Corporate Presentation November 2018 Forward-Looking Statement This presentation includes forward-looking statements that are subject to many risks and uncertainties.
More informationA world leader in allergy immunotherapy. Jefferies Global Healthcare Conference, London : 19 November 2014 : Flemming Pedersen, CFO & EVP
A world leader in allergy immunotherapy ALK at a glance Leading allergy immunotherapy (AIT) specialist AIT: Treats the root cause of allergy Products in all areas of AIT ALK has 33% of the global AIT market
More informationDARA Reports Year-End 2012 Financial Results
April 1, 2013 DARA Reports Year-End 2012 Financial Results Company Provides a Commercial Portfolio and Development Pipeline Business Update RALEIGH, NC -- (MARKETWIRE) -- 04/01/13 -- DARA BioSciences,
More informationINVESTOR PRESENTATION
INVESTOR PRESENTATION May 2018 2 FORWARD-LOOKING INFORMATION The following presentation contains statements that are considered forward-looking information ( FLI ) within the meaning of securities regulation.
More informationInvestor Presentation
Investor Presentation Spring 2019 OTCQX:MDCL www.medicinemantechnologies.com SAFE HARBOR STATEMENT: This presentation may contain forward looking statements which are based on current expectations, forecasts,
More informationPROVIDENT PERSPECTIVE October 2017
PROVIDENT PERSPECTIVE October 2017 Private Equity Investment in Dental Care Creating Long Term Value Dental is a sector that has long been a favorite of the private equity community. Consolidation within
More informationCorporate Presentation
Corporate Presentation January 2019 2018 Chembio. All Rights Reserved. # 2019 Chembio. All Rights Reserved. Page 1 Safe Harbor Statement Statements contained herein that are not historical facts are forward-looking
More informationCorporate Overview. February 2018 NASDAQ: CYTR
Corporate Overview February 2018 NASDAQ: CYTR CytRx Safe Harbor Statement THIS PRESENTATION CONTAINS FORWARD-LOOKING STATEMENTS THAT INVOLVE CERTAIN RISKS AND UNCERTAINTIES. ACTUAL RESULTS COULD DIFFER
More informationWilliam Demant. Jefferies Healthcare Conf. Nov Søren B. Andersson, VP Investor Relations
William Demant Jefferies Healthcare Conf. Nov. 2017 Søren B. Andersson, VP Investor Relations Agenda General update Key take-aways from November Interim Statement Hearing Devices Outlook 2017 Q&A 2 General
More informationQ Investor Kit JANUARY-MARCH 2014
Q1 2014 Investor Kit JANUARY-MARCH 2014 Swedish Match reporting segments Snus and moist snuff Snus (Scandinavia and US) Moist snuff (US) SMPM International Other tobacco products Cigars (US) Chewing tobacco
More informationSAMPLE. Sterilization and Disinfectant Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
Sterilization and Disinfectant Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Reference Code: GDME0165BDB Publication Date: January 2013 GlobalData. This report
More informationA-dec for DSO. Reliability, unparalleled support, and planned efficiency for superior patient care.
A-dec for DSO Reliability, unparalleled support, and planned efficiency for superior patient care. Why A-dec Quality impacts profitability. A-dec understands the importance of keeping your Dental Service
More informationPARTNERSHIP OPPORTUNITIES
PARTNERSHIP OPPORTUNITIES 2018-2019 ABOUT THE BUSINESS LAW SECTION Thank you for considering a partnership with the Business Law Section of The Florida Bar. We are the primary resource for Florida business
More informationInvestor Presentation
Investor Presentation January 2012 Forward Looking Statements Statements contained herein that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933,
More informationBuilding a new model of sustainable chemistry. Meeting with Investors at VFB-Happening 2014 Karim Hajjar CFO
Building a new model of sustainable chemistry Meeting with Investors at VFB-Happening 2014 Karim Hajjar CFO Solvay at a glance Acceleration of Solvay s transformation Delivery in a challenging economic
More informationMedifocus, Inc. OTCQX: MDFZF TSXV: MFS
Medifocus, Inc. OTCQX: MDFZF TSXV: MFS www.medifocusinc.com Develops and commercializes minimally invasive focused heat thermotherapy systems for the treatment of cancer and other diseases January 2014
More informationLeading Intimate Healthcare. Investor presentation Q1 2007/08
Leading Intimate Healthcare Investor presentation Q1 2007/08 1 2 Agenda Introduction to Coloplast Q1 2007/08 in headlines Outlook for 2007/08 Strategic targets Leading intimate healthcare Appendices Q1
More informationTotal Face Group Limited
Total Face Group Limited 2017 Half Year Results Presentation Contents Results Highlights Highlights Half Year Results Revenue Bridge Revenue Breakdown Clinic Profitability Profit & Loss Financial Position
More informationZacks Small-Cap Research
Zacks Small-Cap Research Sponsored Impartial - Comprehensive August 29, 2018 David Bautz, PhD 312-265-9471 dbautz@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Opiant Pharmaceuticals,
More informationNASDAQ CM:BIOL. World Leader in Dental Lasers. Transformational Technology Enabling Better Patient Outcomes
NASDAQ CM:BIOL World Leader in Dental Lasers Transformational Technology Enabling Better Patient Outcomes December 2017 1 Safe Harbor Statement Statements made in this presentation and during discussions
More informationAstraZeneca to acquire MedImmune for $58 per share in a fully recommended, all-cash transaction with a total enterprise value of $15.
[NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO OR FROM AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS
More informationWntResearch. 100% one-week return? 16 October 2017 PRICE EXPECTATIONS INVESTMENT CASE PRICE TRIGGERS PRICE 12 MONTHS COMPANY PROFILE
Occasion: Initial coverage +37% +71% 100% one-week return? s share price has dropped by more than 50% since the announcement of the current and ongoing public offering. In theory the share price should
More informationSAMPLE. Syringes and Needles Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to Reference Code: GDME0166BDB
Syringes and Needles Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Reference Code: GDME0166BDB Publication Date: January 2013 GlobalData. This report is a licensed product
More informationInvestor Presentation
Investor Presentation February 2018 2 FORWARD-LOOKING INFORMATION The following presentation contains statements that are considered forward-looking information ( FLI ) within the meaning of securities
More informationTSX Venture: RVV OTCQB: RVVTF
TSX Venture: RVV OTCQB: RVVTF The image part with relationship ID rid3 was not found in the file. 2017 Annual General and Special Meeting of Shareholders December 19, 2017 Revive Therapeutics Ltd. Office:
More informationSpecial Meeting in Lieu of Annual Meeting of Shareholders
Special Meeting in Lieu of Annual Meeting of Shareholders Thursday, June 19, 2008 James A. Bianco, M.D. President and CEO Agenda Call meeting to order Introduction of the inspector of elections, secretary,
More informationFORM8-K HILLENBRAND,INC.
UNITEDSTATES SECURITIESANDEXCHANGECOMMISSION Washington,D.C.20549 FORM8-K CURRENTREPORT PursuanttoSection13or15(d)oftheSecuritiesExchangeActof1934 Date of Report (Date of earliest event reported): December18,2015
More informationNeovasc Inc. Alexei Marko, CEO. January 2012 OneMedForum
Neovasc Inc. Alexei Marko, CEO January 2012 OneMedForum 2 Forward-Looking Statements Statements contained herein that are not based on historical or current fact, including without limitation statements
More informationChronic Care North America update Coloplast Capital Markets Day 2018 Manu Varma, Senior Vice President, Chronic Care Management, NA
Chronic Care North America update Coloplast Capital Markets Day 2018 Manu Varma, Senior Vice President, Chronic Care Management, NA US Chronic Care has outperformed the market by a factor 2-3x and continues
More informationChina Portable Medical Electronic Devices Industry Report, 2010
China Portable Medical Electronic Devices Industry Report, 2010 Portable medical electronic devices can be mainly divided into home type and professional type, of which, the former covers electronic sphygmomanometer,
More informationSEO CASE STUDY KIDS KLUB DENTISTRY
SEO CASE STUDY KIDS KLUB DENTISTRY Our mission is to provide state-of-theart website design and web marketing solutions at an affordable price to the dental community, while maintaining customer service
More informationEllex Medical Lasers (ASX: ELX)
Ellex Medical Lasers (ASX: ELX) Investor Presentation March 2012 Tom Spurling, Chief Executive 82 Gilbert Street, Adelaide, Australia Phone +61 8 8104 5200 tspurling@ellex.com Ellex in a snapshot Global
More informationMyriad Genetics Fiscal First-Quarter 2017 Earnings Call 11/01/2016
Myriad Genetics Fiscal First-Quarter 2017 Earnings Call 11/01/2016 1 Forward Looking Statements Forward Looking Statements Some of the information presented here today may contain projections or other
More informationAPPLIANCE TELECOMMUNICATIONS
May 2001 1 DEVICE CRT PDP CRT components APPLIANCE Air Conditioner Refrigerator Washing machine Cooking appliance DISPLAY& MEDIA TV / Monitor CD-ROM DVD products VCR / PC / PCB TELECOMMUNICATIONS Switching
More informationDIGITAL DIABETES CARE MARKET READY TO TAKE OFF
DIGITAL DIABETES CARE MARKET 2018-2022 READY TO TAKE OFF www.research2guidance.com A market study about diabetes apps, connected devices, and services 3 rd edition, 3 rd September 2018 Research2Guidance
More informationSPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS
SPHERIX Investor Relations Phone: (301) 897-2564 Email: info@spherix.com SPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS BETHESDA, MD, May 21, 2010 - Spherix Incorporated (NASDAQ CM: SPEX), an innovator
More informationGN Store Nord Goldman Sachs European Medtech and Healthcare Services Conference. CEO GN ReSound, Mike van der Wallen September 3, 2008
GN Store Nord Goldman Sachs European Medtech and Healthcare Services Conference CEO GN ReSound, Mike van der Wallen September 3, 2008 GN Store Nord A/S GN GN Store Store Nord Nord Listed Listed company
More informationShareholder Presentation 2017 NYSE MKT: ISR
Shareholder Presentation 2017 NYSE MKT: ISR Safe Harbor Statement Statements in this presentation about IsoRay's future expectations, including: the advantages of our products and their delivery systems,
More informationNordea investor meeting. June 18 th, 2018 Kristian Villumsen, EVP Chronic Care
Nordea investor meeting June 18 th, 2018 Kristian Villumsen, EVP Chronic Care Chronic Care represents more than 75% of Coloplast sales and we continue to outgrow the market FY 15/16 Chronic Care Rest of
More informationA GAME PLAN FOR THE GAME CHANGERS IN ORTHODONTICS
A GAME PLAN FOR THE GAME CHANGERS IN ORTHODONTICS By Roger P. Levin, DDS Ortho Production Whitepaper Series For Ortho2 Users Bonus LG120118 Copyright 2018 by Levin Group, Inc. 888.973.0000 WWW.LEVINGROUP.COM
More informationPutting ALK on the right growth trajectory
Putting ALK on the right growth trajectory Økonomisk Ugebrevs Kapitalmarkedseftermiddag 15. marts 2018 Per Plotnikof, VP Corporate Communications and IR Marts 2018 Allergy: a global disease with a large
More information